Lincoln Pharmaceuticals consolidated net profit rises 29.64% in the September 2016 quarter

Sales decline 18.53% to Rs 74.27 crore
Net profit of Lincoln Pharmaceuticals rose 29.64% to Rs 8.66 crore in the quarter ended September 2016 as against Rs 6.68 crore during the previous quarter ended September 2015. Sales declined 18.53% to Rs 74.27 crore in the quarter ended September 2016 as against Rs 91.16 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales74.2791.16 -19 OPM %19.5812.87 -PBDT12.779.86 30 PBT11.498.75 31 NP8.666.68 30Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 11 2016 | 5:52 PM IST
